financetom
Business
financetom
/
Business
/
PAR Technology Swings to Q2 Adjusted Earnings, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PAR Technology Swings to Q2 Adjusted Earnings, Revenue Rises
Aug 8, 2025 5:18 AM

07:54 AM EDT, 08/08/2025 (MT Newswires) -- PAR Technology ( PAR ) reported Q2 adjusted earnings Friday of $0.03 per diluted share, swinging from a loss of $0.23 a year earlier.

Analysts polled by FactSet expected earnings of $0.01.

Revenue for the quarter ended June 30 was $112.4 million, compared with $78.2 million a year earlier.

Analysts surveyed by FactSet expected $110.8 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Targa Resources Rebuffed Takeover Interest From Larger Rival Williams- Bloomberg News
BRIEF-Targa Resources Rebuffed Takeover Interest From Larger Rival Williams- Bloomberg News
Sep 6, 2024
Sept 4 (Reuters) - * TARGA RESOURCES REBUFFED TAKEOVER INTEREST FROM LARGER RIVAL WILLIAMS- BLOOMBERG NEWS Source text: https://tinyurl.com/26bpvbjt Further company coverage: ...
Collegium Closes Acquisition of Ironshore Therapeutics; Boosts 2024 Product Revenue
Collegium Closes Acquisition of Ironshore Therapeutics; Boosts 2024 Product Revenue
Sep 6, 2024
09:59 AM EDT, 09/04/2024 (MT Newswires) -- Collegium Pharmaceutical ( COLL ) said Wednesday that it has completed its $525 million, all-cash acquisition of Ironshore Therapeutics, which markets and distributes the Jornay PM drug treatment for attention deficit hyperactivity disorder. Collegium said it now expects to generate between $620 million to $635 million in product revenue this year, up from...
Abbott Launches Trial to Assess Use of Deep Brain Stimulation System to Manage Depression
Abbott Launches Trial to Assess Use of Deep Brain Stimulation System to Manage Depression
Sep 6, 2024
09:52 AM EDT, 09/04/2024 (MT Newswires) -- Abbott Laboratories ( ABT ) said Wednesday it has started a study to assess the use of its deep brain stimulation system to manage treatment-resistant depression. The US Food and Drug Administration has given Abbott breakthrough device designation to explore the use of the system to treat the disease, the company said. The...
Equinix Issues Over $750 Million in Green Bonds
Equinix Issues Over $750 Million in Green Bonds
Sep 6, 2024
09:58 AM EDT, 09/04/2024 (MT Newswires) -- Equinix ( EQIX ) said Wednesday that it has issued more than $750 million in green bonds from two completed offerings. The digital infrastructure company said that with the issuance it will have issued a total of approximately $5.6 billion of green bonds. Equinix ( EQIX ) said it plans to allocate the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved